Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Compare fees between Total Market and Total World Retirement to understand how costs affect long-term returns and diversification.
28,634 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Global defense markets are shifting as the US, Russia, and China advance missile programs. This report examines inves...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
June inflation data surprised to the downside, lifting Bitcoin and other risk assets. Yet traders remain wary of a Se...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
As Autohome reports Q1 2026 earnings, investors get a clear read on user momentum, ad revenue, and margin discipline....
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
A wave of new analyst ratings hits screens Friday, touching auto parts, semiconductors, software and biotech. Upgrade...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
Oil futures closed above $100 a barrel for the first time in years, driven by Iran's vow to block the Strait of Hormu...